23andMe Holding Other Share Holders Equity 2021-2024 | MEHCQ

23andMe Holding other share holders equity from 2021 to 2024. Other share holders equity can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
23andMe Holding Annual Other Share Holders Equity
(Millions of US $)
2024 $
2023 $
2022 $
2021 $
2020 $
2020 $0
23andMe Holding Quarterly Other Share Holders Equity
(Millions of US $)
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30 $0
2020-06-30 $0
2020-03-31 $0
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.000B $0.220B
23andMe Inc. is a consumer genetics and research company. It involved in discovery programs rooted in human genetics across a spectrum of disease areas, including oncology, respiratory and cardiovascular diseases, in addition to other therapeutic areas. 23andMe Inc., formerly known as VG Acquisition Corp., is headquartered in Sunnyvale, CA.
Stock Name Country Market Cap PE Ratio
JOYY (JOYY) Singapore $2.260B 8.95
Lytus Technologies Holdings PTV (LYTHF) India $0.000B 0.00